Overview
Status
Active
Registry date
2025-02-10
Registered address
160, 38-120 Nowa Wieś, Poland
Financials
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 16.92mMedianUSD 344.81kAverageUSD 8.15m
Net profit
This companyUSD 3.17mMedianUSD 4.87kAverageUSD 684.24k
Operating costs
This companyUSD 12.75mMedianUSD 396.72kAverageUSD 7.18m
Assets
This companyUSD 10.15mMedianUSD 373.21kAverageUSD 7.89m
Industry
Bank accounts
Registered as a VAT taxpayer on 2011-10-11. Active
06 1750 1224 0000 0000 3402 6947
09 1750 1224 0000 0000 3402 6602
19 1020 4391 0000 6802 0245 0021
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
20 public aid cases recorded, with a total value of $158,307.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | PGE Obrót S.A. | |
| Oct 6, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | STAROSTA STRZYŻOWSKI | |
| Feb 26, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | STAROSTA STRZYŻOWSKI |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-01 | Rozwój eksportu firmy SYMBIOFARM Sp. z o.o. | $89,005$89,005 | Program Operacyjny Polska Wschodnia |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Michał Tomczyk — Attorney-in-fact (sole)
Manner of representation
Each of the general partners acting independently is authorized to represent the company. The authorization to represent covers all judicial and extrajudicial acts.
Partners
| Partners |
|---|
Paweł Krok (53)Marital property agreement (separation) |
Michał Tomczyk |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | ||
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu | ||
| Yangosp. z o.o. | $8,214,312.60 | yango.pl | ||
| OnesanoS.A. | $3,063,535.91 | onesano.pl |
FAQ
The main business activity of Symbiofarm Krok focuses on manufacture of food supplements.
The company was registered in the Polish National Court Register (KRS) on February 10, 2025.
The headquarters is located at: 160, 38-120 Nowa Wieś.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from February 10, 2025 to December 31, 2025.
The company reported a revenue of USD 16,922,181 in 2025.
Yes, in 2025 the company was profitable, achieving a net profit of USD 3,173,426.
The largest operating cost category falls under materials and energy. This category amounted to USD 8,169,839 in 2025, representing 64% of all operating expenses.
Last updated: 2026-09-25